UKIACR average (population) | UKIACR average (country) | England | Scotland | Wales | Northern Ireland | Republic of Ireland | |
---|---|---|---|---|---|---|---|
All invasive xnmsc | 58.9% | 55.1% | 60.3% | 58.5% | 40.3% | 61.0% | 55.2% |
All xnmsc 0-24 | 29.9% | 26.8% | 30.8% | 39.3% | 9.3% | 31.4% | 23.1% |
All xnmsc 25-59 | 65.9% | 61.9% | 67.4% | 67.0% | 48.7% | 68.7% | 58.0% |
All xnmsc 60-79 | 63.2% | 58.7% | 64.9% | 62.7% | 42.0% | 65.5% | 58.4% |
All xnmsc 80+ | 42.2% | 38.9% | 43.4% | 38.6% | 29.7% | 40.8% | 41.9% |
All registrations | 45.2% | 41.5% | 45.8% | NA | NA | NA | 37.2% |
Haematology | 15.8% | 21.5% | 13.9% | 41.2% | 1.3% | 10.1% | 40.8% |
Head and Neck | 79.9% | 75.3% | 81.4% | 83.8% | 66.6% | 82.0% | 62.9% |
Lower GI | 78.9% | 75.9% | 80.2% | 79.6% | 61.6% | 83.8% | 74.2% |
Upper GI | 77.2% | 71.5% | 79.3% | 75.4% | 60.7% | 71.3% | 70.9% |
HPB | 27.7% | 25.8% | 28.6% | 23.0% | 16.0% | 27.8% | 33.5% |
Trachea, Bronchus & Lung | 28.7% | 27.6% | 29.4% | 26.8% | 20.3% | 32.1% | 29.4% |
Melanoma | 1.0% | 0.7% | 1.1% | 0.1% | 0.6% | 0.0% | 1.9% |
Breast | 94.1% | 89.4% | 96.0% | 88.4% | 87.7% | 94.6% | 80.0% |
Cervix | 79.3% | 73.7% | 82.0% | 80.5% | 82.0% | 76.5% | 47.7% |
Other Female Genitals | 75.0% | 71.9% | 76.2% | 74.4% | 64.4% | 81.6% | 62.9% |
Prostate | 79.9% | 71.0% | 83.0% | 86.6% | 26.8% | 82.8% | 75.9% |
Bladder | 84.7% | 77.0% | 87.4% | 83.6% | 65.0% | 88.7% | 60.5% |
Kidney | 59.5% | 52.1% | 61.8% | 61.5% | 12.1% | 71.7% | 53.4% |
Brain and CNS | 68.4% | 64.1% | 70.3% | 69.0% | 14.4% | 91.2% | 75.5% |
Thyroid and other endocrine glands | 18.7% | 15.4% | 20.0% | 9.7% | 21.1% | 15.0% | 11.3% |
CUP | 22.4% | 19.0% | 23.3% | 21.9% | 9.7% | 13.5% | 26.7% |
Other invasive cancer | 30.4% | 27.2% | 31.6% | 30.9% | 10.4% | 38.9% | 24.2% |
Other tumours | 41.8% | 28.5% | 44.0% | NA | NA | 12.9% | NA |
Non-Melanoma Skin Cancer | 17.5% | 19.8% | 16.3% | 26.1% | 31.2% | 3.7% | 21.8% |